MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
ZyVersa Therapeutics, Inc. (ZVSA)
ZyVersa Therapeutics, Inc. (ZVSA)
source: myfinsight.com
Download
Download image
Proceeds from issuance of
convertible notes and...
$1,000,000
Net cash provided by
financing activities
$1,000,000
Net increase in cash
$200,882
Canceled cashflow
$799,118
Accrued expenses and
other current...
$548,225
Fair value option
loss on convertible...
-$344,000
Accounts payable
$111,885
Stock-based compensation
$55,872
Change in fair value of
equity payable
$28,171
Vendor deposits
$14,484
Net cash used in
operating activities
-$799,118
Canceled cashflow
$1,102,637
Net loss
-$1,793,381
Prepaid expenses and
other current assets
$92,374
Change in fair value of
warrant liabilities
-$16,000
Back